Vantage Consulting Group’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,258
Closed -$25K 1025
2020
Q4
$25K Buy
+1,258
New +$25K ﹤0.01% 779